Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Press release

BioStock: CLS presents study results and board changes

Clinical Laserthermia Systems

Despite CLS' decision to focus on commercialisation within neurosurgery, the company continues to present study results supporting the use of the TRANBERG system for the treatment of prostate cancer. Meanwhile, the company has announced a change in the board - Lars-Erik Eriksson, board member, former CEO, and co-founder, has decided to step down from his position. 

Read the full article at biostock.se:

https://www.biostock.se/en/2025/02/cls-presents-study-results-and-board-changes/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.